Epidemiology and Course of Clostridioides difficile Infections in Germany: Retrospective Analysis of German Health Claims Data
Despite declining incidence and recurrence rates, CDI remains a major health burden in Germany, especially for older adults. High severity, limited adherence to treatment guidelines, and excess mortality underscore the need for targeted prevention, individualized therapy, and improved guideline implementation.
Authors
- Julia Puschmann (ORCID: https://orcid.org/0000-0002-0226-219X)
- Jean Krampe
- Anna Seiffert
- Sebastian Wingen‐Heimann (ORCID: https://orcid.org/0000-0002-4232-6944)
- Siegfried Noack
- Nils‐Olaf Hübner (ORCID: https://orcid.org/0000-0002-6095-4936)
- Christoph Lübbert
Institutions
- Universitätsmedizin Greifswald (DE)
- Klinikum St. Georg (DE)
- Düsseldorf University Hospital (DE)
- Integrated Oncology (United States) (US)
- German Center for Infection Research (DE)
- Tillotts Pharma (Switzerland) (CH)
- University Hospital Leipzig (DE)
- Cologne Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases (DE)
- University Hospital Cologne (DE)
- Heinrich Heine University Düsseldorf (DE)
- Leipzig University (DE)
Publication Details
- Journal
- Infectious Diseases and Therapy
- Published
- 2025-09-01
- DOI
- https://doi.org/10.1007/s40121-025-01223-1
- Citations
- 1
- Primary Topic
- Clostridium difficile and Clostridium perfringens research
- Type
- article
- Field-Weighted Citation Impact
- 1.40
Funders
- Tillotts Pharma